Amivas (US), LLC products

A Severe Malaria Treatment, Vital for the US Healthcare Community. No FDA-approved injectable malaria medication has been available in the US since IV quinidine was discontinued in early 2019. Artesunate for Injection fills this need.

Artesunate for Injection is an antimalarial indicated for the initial treatment of severe malaria in adults and children.